BMI View: Government initiatives to boost the nascent domestic pharmaceutical industry and reduce the
reliance on imports will limit the attractiveness of Belarus to multinational drugmakers. Government
interference, in the form of domestic bias in the medicine tendering process and pricing controls, will
further reduce revenue earning opportunities. Additional risks include a continued poor economic forecast
and rising regional geopolitical tensions.
Headline Expenditure Projections
Pharmaceuticals: BYR12,247bn in 2015 (USD801mn) to BYR14,219bn (USD783mn) in 2016; +16.1% in
local currency terms and -2.1% in US dollar terms.
Healthcare: BYR60,885bn (USD3.98bn) in 2015 to BYR71,906bn (USD3.96bn) in 2016; +18.1% in local
currency terms and -0.4% in US dollar terms.

Table of Contents

BMI Industry View 7
Table: Headline Pharmaceuticals & Healthcare Forecasts (Belarus 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belarus 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belarus 2012-2020) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Belarus 2014-2020) 29
Table: Pharmaceutical Trade Data And Forecasts local currency (Belarus 2014-2020) 29
Industry Risk Reward Index 30
Central And Eastern Europe Risk/Reward Index 30
Belarus Risk/Reward Index 36
Rewards 36
Risks 37
Regulatory Review 39
Intellectual Property Issues 41
Pricing And Reimbursement Regime 42
Market Overview 45
Healthcare Sector 46
Table: Healthcare Resources (Belarus 2010-2015) 49
Table: Healthcare Personnel (Belarus 2010-2015) 49
Table: Healthcare Activity (Belarus 2010-2015) 50
Research And Development 50
Clinical Trials 51
Epidemiology 52
Competitive Landscape 56
Research-Based Industry 56
Table: Multinational Market Activity 57
Generic Drugmakers 58
Pharmaceutical Distribution 59
Pharmaceutical Retail Sector 60
Company Profile 61
Lekpharm 61
Demographic Forecast 64
Demographic Outlook 64
Table: Population Headline Indicators (Belarus 1990-2025) 65
Table: Key Population Ratios (Belarus 1990-2025) 65
Table: Urban/Rural Population & Life Expectancy (Belarus 1990-2025) 66
Table: Population By Age Group (Belarus 1990-2025) 66
Table: Population By Age Group % (Belarus 1990-2025) 67
Glossary 69
Methodology 71
Pharmaceutical Expenditure Forecast Model 71
Healthcare Expenditure Forecast Model 71
Notes On Methodology 72
Risk/Reward Index Methodology 73
Index Overview 74
Table: Pharmaceutical Risk/Reward Index Indicators 74
Indicator Weightings 75

List of Tables

Table: Headline Pharmaceuticals & Healthcare Forecasts (Belarus 2014-2020)
Table: Pharmaceutical Sales, Historical Data And Forecasts (Belarus 2012-2020)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Belarus 2012-2020)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Belarus 2012-2020)
Table: Pharmaceutical Trade Data And Forecasts (Belarus 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Belarus 2014-2020)
Table: Healthcare Resources (Belarus 2010-2015)
Table: Healthcare Personnel (Belarus 2010-2015)
Table: Healthcare Activity (Belarus 2010-2015)
Table: Multinational Market Activity
Table: Population Headline Indicators (Belarus 1990-2025)
Table: Key Population Ratios (Belarus 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Belarus 1990-2025)
Table: Population By Age Group (Belarus 1990-2025)
Table: Population By Age Group % (Belarus 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators